Latest Investor Confidence News

Micro-X has raised $6.18 million through a placement that sees strategic partner Billion Prima increase its stake to 8.6%, funding key commercial and manufacturing scale-up initiatives in medical imaging.

Cleo Diagnostics has raised $5 million to support the U.S. commercial launch of its Pre-Surgical Ovarian Cancer Test and accelerate development of a mass screening test, signaling strong investor confidence in its technology.

MONEYME has locked in a $300 million credit card warehouse financing facility with improved pricing, setting the stage for its new credit card product launch in 2026.

The Calmer Co. International Limited has completed a $1.4 million convertible note raise, positioning itself to accelerate wholesale growth and inventory build ahead of 2026.

Cassius Mining Limited has raised $1.16 million through a share placement to fund its Soalara project in Madagascar and support ongoing litigation in Ghana.

Rapid Critical Metals has announced the discovery of a new parallel silver lode at its Webbs Silver Project in northern New South Wales, following a 2,000-metre diamond drilling program. Early results reveal strong silver mineralisation, opening promising avenues for resource expansion.

Harmoney Corp Limited reported a staggering 742% increase in Cash NPAT for FY25, driven by its new Stellare® 2.0 platform and operational efficiencies. The company reaffirmed its ambitious $12 million profit target for FY26 while unveiling a secured car loan product and securing a major bank debt facility.

Bendigo and Adelaide Bank has announced a fully franked quarterly dividend of AUD 1.311 per security on its Capital Note BENPH, payable in March 2026. This distribution reflects a steady income stream aligned with the terms set out in the 2020 prospectus.

Wellnex Life reports encouraging early results from its turnaround strategy, posting a modest EBITDA profit and robust sales growth for its Pain Away brand.

Aureka Limited has raised $3.6 million through a share placement to fund a second diamond drill rig and accelerate exploration at its Victorian gold projects, reflecting strong investor confidence following recent high-grade discoveries.

Recce Pharmaceuticals has won a significant Australian Government R&D tax incentive, unlocking up to A$85 million for its synthetic anti-infective programs worldwide, including a pivotal Phase 3 clinical trial.

Sunrise Energy Metals has raised A$32.5 million through a follow-on placement, advancing its flagship Syerston Scandium Project toward mid-2026 construction. This latest capital injection builds on a total of A$105 million raised since June 2025, underscoring strong investor confidence amid growing scandium demand.